Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kura Oncology (KURA) EBT Margin (2024 - 2025)

Kura Oncology (KURA) has disclosed EBT Margin for 2 consecutive years, with 466.82% as the latest value for Q4 2025.

  • On a quarterly basis, EBT Margin fell 473456.0% to 466.82% in Q4 2025 year-over-year; TTM through Dec 2025 was 738.3%, a 1135998.0% decrease, with the full-year FY2025 number at 412.51%, down 9336.0% from a year prior.
  • EBT Margin was 466.82% for Q4 2025 at Kura Oncology, down from 357.19% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 14974.61% in Q1 2025 to a low of 466.82% in Q4 2025.